24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
18/10/2017
The Sixth Ideas Generation Program Sponsored by the Barcelona Synchrotron Park Has Begun
12/10/2017
Barcelona Synchrotron Park's commitment to Biodiversity
02/10/2017
8 Congresses at the same time: it’s the Barcelona Industry Week!
26/09/2017
50th anniversary: congratulations UAB!
21/09/2017
More than 7,000 foreign companies in Catalonia
13/09/2017
How ALBA Synchrotron Works